BIND Biosciences Secures $1,400,000 Series C Financing
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2371f5e4-c699-497f-a237-08fe98521b5a&Preview=1
Date 6/29/2010
Company Name BIND Biosciences
Mailing Address 64 Sidney Street Cambridge, MA 02139
Company Description BIND Biosciences, Inc. is a venture backed biopharmaceutical company focused on engineering targeted therapeutics. BIND’s technology was developed by world class laboratories at MIT and Harvard.
Proceeds Purposes The company plans to use some of the new funding to usher its first drug-loaded nanoparticle into a Phase I clinical study for treating solid tumors.